On 3 February 2017, the U.S. Federal Trade Commission (FTC) released its Merger Remedies Study, which analyzed the success of merger remedies imposed by the FTC from 2006 to 2012. Nearly two decades after it issued a similar...more
2/15/2017
/ Antitrust Provisions ,
Best Practices ,
Business Assets ,
Competition ,
Corporate Counsel ,
Divestiture ,
Due Diligence ,
Federal Trade Commission (FTC) ,
Merger Controls ,
Pharmaceutical Industry ,
Remedies ,
Supply Agreements ,
Third-Party Relationships ,
Transition Team ,
Vetting